Evidence map›Paper›PMID 34986160›Full record

ArticlePLoS neglected tropical diseases2022

Thrombospondin-1 expression and modulation of Wnt and hippo signaling pathways during the early phase of Trypanosoma cruzi infection of heart endothelial cells.

Ashutosh Arun, Kayla J Rayford, Ayorinde Cooley, Tanu Rana, Girish Rachakonda, Fernando Villalta, Siddharth Pratap, Maria F Lima, Nader Sheibani, Pius N Nde

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Immune network · 2022
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ashutosh ArunDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.
Kayla J RayfordDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.
Ayorinde CooleyDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.ORCID 0000-0002-8710-6910
Tanu RanaDepartment of Professional Medical Education and Molecular Biology Core Facility, Meharry Medical College, Nashville, Tennessee, United States of America.
Girish RachakondaDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.ORCID 0000-0003-4331-8994
Fernando VillaltaDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.
Siddharth PratapSchool of Graduate Studies and Research, Meharry Medical College, Nashville, Tennessee, United States of America.ORCID 0000-0003-2200-0848
Maria F LimaSchool of Graduate Studies and Research, Meharry Medical College, Nashville, Tennessee, United States of America.ORCID 0000-0001-8835-5700
Nader SheibaniDepartment of Ophthalmology and Visual Sciences, Biomedical Engineering, and Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.ORCID 0000-0003-2723-9217
Pius N NdeDepartment of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, United States of America.ORCID 0000-0001-7101-7721
Meharry Medical College · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Samuel Evans Adunyah, JAMES E HILDRETH · 2017 to 2026
$48.2M
THE MEHARRY RISE INITIATIVER25GM059994 · NIGMS · MEHARRY MEDICAL COLLEGE · PI MOTLEY-JOHNSON, EVANGELINE D · 1999 to 2021
$23.0M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
Research Training in Cardivascular Biology at MeharryT32HL007737 · NHLBI · MEHARRY MEDICAL COLLEGE · PI MARTIN, PAMELA M · 1993 to 2025
$4.7M
MOLECULAR PARASITOLOGY TRAINING PROGRAMT32AI007281 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 1985 to 2025
$3.2M
Investigating oxygen metabolism in diabetic retinopathyR01EY026078 · NEI · NORTHWESTERN UNIVERSITY · PI SHEIBANI, NADER, ZHANG, HAO F · 2016 to 2020
$2.3M
Molecular mechanisms of Trypanosoma cruzi cardiopathogenesisSC1AI127352 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 2016 to 2019
$1.5M
Molecular mechanisms of Trypanosoma cruzi induced colon pathogenesisF31AI167579 · NIAID · MEHARRY MEDICAL COLLEGE · PI RAYFORD, KAYLA · 2022 to 2023
$94k
NCI NIH HHS P30 CA014520NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY026078NHLBI NIH HHS T32 HL007737NIAID NIH HHS F31 AI167579NIAID NIH HHS SC1 AI127352NIAID NIH HHS T32 AI007281NIGMS NIH HHS R25 GM059994NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

The protozoan parasite, Trypanosoma cruzi, causes severe morbidity and mortality in afflicted individuals. Approximately 30% of T. cruzi infected individuals present with cardiac pathology. The invasive forms of the parasite are carried in the vascular system to infect other cells of the body. During transportation, the molecular mechanisms by which the parasite signals and interact with host endothelial cells (EC) especially heart endothelium is currently unknown. The parasite increases host thrombospondin-1 (TSP1) expression and activates the Wnt/β-catenin and hippo signaling pathways during the early phase of infection. The links between TSP1 and activation of the signaling pathways and their impact on parasite infectivity during the early phase of infection remain unknown. To elucidate the significance of TSP1 function in YAP/β-catenin colocalization and how they impact parasite infectivity during the early phase of infection, we challenged mouse heart endothelial cells (MHEC) from wild type (WT) and TSP1 knockout mice with T. cruzi and evaluated Wnt signaling, YAP/β-catenin crosstalk, and how they affect parasite infection. We found that in the absence of TSP1, the parasite induced the expression of Wnt-5a to a maximum at 2 h (1.73±0.13), P< 0.001 and enhanced the level of phosphorylated glycogen synthase kinase 3β at the same time point (2.99±0.24), P<0.001. In WT MHEC, the levels of Wnt-5a were toned down and the level of p-GSK-3β was lowest at 2 h (0.47±0.06), P< 0.01 compared to uninfected control. This was accompanied by a continuous significant increase in the nuclear colocalization of β-catenin/YAP in TSP1 KO MHEC with a maximum Pearson correlation coefficient of (0.67±0.02), P< 0.05 at 6 h. In WT MHEC, the nuclear colocalization of β-catenin/YAP remained steady and showed a reduction at 6 h (0.29±0.007), P< 0.05. These results indicate that TSP1 plays an important role in regulating β-catenin/YAP colocalization during the early phase of T. cruzi infection. Importantly, dysregulation of this crosstalk by pre-incubation of WT MHEC with a β-catenin inhibitor, endo-IWR 1, dramatically reduced the level of infection of WT MHEC. Parasite infectivity of inhibitor treated WT MHEC was similar to the level of infection of TSP1 KO MHEC. These results indicate that the β-catenin pathway induced by the parasite and regulated by TSP1 during the early phase of T. cruzi infection is an important potential therapeutic target, which can be explored for the prophylactic prevention of T. cruzi infection.

Indexed as

Active Transport, Cell NucleusAnimalsbeta CateninChagas DiseaseEndothelial CellsEndotheliumGlycogen Synthase Kinase 3 betaHeartHippo Signaling PathwayMiceMice, KnockoutRatsThrombospondin 1Trypanosoma cruziWnt-5a ProteinWnt Signaling Pathwaybeta CateninGlycogen Synthase Kinase 3 betaThbs1 protein, mouseThrombospondin 1Wnt-5a ProteinWnt5a protein, mouseYap1 protein, mouseYAP-Signaling Proteins

Identifiers

PMID34986160
PMCPMC8730400
OpenAlexW4206408183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.